Richard Smith

Richard Smith

McDermott Will & Emery

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Inside M&A - Summer 2014

“Commercially Reasonable Efforts” Diligence Obligations in Life Science M&A" - More than 80 percent of all deals in the pharmaceutical, medical device and biotech industries include an earnout structure that provides...more

5/30/2014 - Best Efforts Clauses Biotechnology Commercially Reasonable Efforts Contingent Payment Clauses Good Faith Life Sciences Medical Devices Milestone Payments Pharmaceutical Popular

1 Results
|
View per page
Page: of 1